ArticleNeuro-oncology2025

A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma.

Patrick Y Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.